SERPINA1 and pachyonychia congenita: Next, we explored the potential association of plasma levels of fuco-SERPINA1, SERPINA1 and CA19-9 with different clinicopathological characteristics (gender, age, TNM stage, tumor stage, lymph node metastasis and distant metastasis) of enrolled PC patients (Table 4 and Table S4).